Assess the quality of life of osteosarcoma patients.
Not Applicable
- Conditions
- Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system
- Registration Number
- CTRI/2021/01/030177
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Histologically proven, osteosarcoma patients of either gender, whose age is 18 years and above, chemo naive, which have been diagnosed and planned their treatment (curative or palliative) at Tata Memorial Centre.
2) Patients who knows English, Hindi or Marathi language.
Exclusion Criteria
1) Patients refused to give consent.
2) Patient below 18 years of age.
3) Partially treated before.
4) Histologically uncertain diagnosis of osteosarcoma.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the quality of life of osteosarcoma patients treated with curative intent. <br/ ><br> <br/ ><br>To study the quality of life of osteosarcoma patients treated with palliative intent (on palliative chemotherapy or only on best supportive care). <br/ ><br>Timepoint: 1) Baseline <br/ ><br>2) At 3-6 months after chemotherapy (approximately 6-9 months from the decision to treat) <br/ ><br> <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1) To study the toxicities associated with chemotherapy for osteosarcoma patients. <br/ ><br>2) To see the variables affecting the quality of life in patients with osteosarcoma. <br/ ><br>Timepoint: 1) Baseline <br/ ><br>2) At 3-6 months after chemotherapy (approximately 6-9 months from the decision to treat) <br/ ><br> <br/ ><br> <br/ ><br>